Enalapril-induced Apoptosis of Acute Promyelocytic Leukaemia Cells Involves STAT5A

In this study, we aimed at evaluating the cytotoxic and apoptotic effects of enalapril on human HL60 acute promyelocytic leukaemia cells and at clarifying the roles of signal transducers and activator of transcription proteins (STATs) on enalapril-induced cell death. Cell viability and cytotoxicity...

Full description

Saved in:
Bibliographic Details
Published in:Anticancer research Vol. 32; no. 7; pp. 2885 - 2893
Main Authors: PURCLUTEPE, Ozlem, ISKENDER, Guniz, SAYDAM, Guray, DEMET KIPER, Hatice, TEZCANLI, Burcin, SELVI, Nur, BIRAY AVCI, Cigir, KOSOVA, Buket, ADAN GOKBULUT, Aysun, SAHIN, Fahri, BARAN, Usuf
Format: Journal Article
Language:English
Published: Attiki International Institute of Anticancer Research 01-07-2012
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In this study, we aimed at evaluating the cytotoxic and apoptotic effects of enalapril on human HL60 acute promyelocytic leukaemia cells and at clarifying the roles of signal transducers and activator of transcription proteins (STATs) on enalapril-induced cell death. Cell viability and cytotoxicity tests were conducted by Trypan blue dye exclusion and 2,3-Bis[2-methoxy-4-nitro-5-sulphophenyl]-2H-tetrazolium-5-carboxanilide inner salt (XTT) assays, respectively. Apoptotic analyses were performed by the AnnexinV-enhanced green fluorescent protein (EGFP) staining method and by fluorescence microscopy. Expression levels of STAT3, -5A and -5B genes were analysed by quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR). The results showed that enalapril reduced viability and proliferation, and induced apoptosis in HL60 cells in a dose- and time-dependent manner as compared to untreated controls. The expression levels of STAT5A gene were significantly reduced in enalapril-treated HL60 cells as compared to untreated controls. Taken together, all data showed for the first time that enalapril has significant anticancer potential for the treatment of acute premyelocytic leukaemia.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0250-7005
1791-7530